Related Experiment Video
Updated: May 9, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Hypertension after kidney transplantation: a pathophysiologic approach
Beje Thomas1, David J Taber, Titte R Srinivas
1Division of Nephrology, Medical University of South Carolina, 96 Jonathan Lucas Street CSB 829, Charleston, SC, 29425, USA, thombeje@musc.edu.
Current Hypertension Reports
|August 13, 2013
Summary
Post-transplant hypertension, often poorly controlled, significantly impacts survival and cardiovascular health. Key risk factors include immunosuppressive drugs like glucocorticoids and calcineurin inhibitors, necessitating tailored treatment strategies.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Post-transplant hypertension is a common complication, negatively affecting graft and patient survival and increasing cardiovascular morbidity.
- It is frequently poorly managed, with significant risk factors including immunosuppressive medications, surgical complications, delayed graft function, and rejection.
- Immunosuppressants, particularly glucocorticoids and calcineurin inhibitors, contribute to hypertension through increased vascular tone, sympathetic activity, and fluid retention.
Purpose of the Study:
- To review the risk factors and pathophysiology of post-transplant hypertension.
- To discuss current approaches to managing hypertension in renal transplant recipients.
- To highlight the need for further research specific to this population.
Main Methods:
- Literature review of risk factors, pathophysiology, and treatment of post-transplant hypertension.
- Analysis of the role of immunosuppressive medications in hypertension development.
- Examination of current evidence-based treatment guidelines.
Main Results:
- Key risk factors identified: immunosuppressive drugs (glucocorticoids, calcineurin inhibitors), surgical issues, delayed graft function, rejection, and donor/recipient factors.
- Immunosuppressants induce hypertension via multifactorial mechanisms including vascular/sympathetic tone and salt/fluid retention.
- Current treatment strategies are largely extrapolated from general hypertensive populations.
Conclusions:
- Post-transplant hypertension is multifactorial and often poorly controlled, impacting long-term outcomes.
- Treatment should be individualized based on comorbidities and specific pathophysiology.
- There is a critical need for dedicated research on the diagnosis and management of hypertension in renal transplant recipients.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...